Aurobindo Pharma informs about press release

26 May 2022 Evaluate

Aurobindo Pharma has informed that it enclosed copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Pemetrexed for Injection.

The above information is a part of company’s filings submitted to BSE.



Aurobindo Pharma Share Price

1401.10 5.10 (0.37%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.